title: Leukocyte infiltration in experimental stroke.
abstract: Stroke is one of the leading causes of death worldwide. At present, the only available treatment is thrombolysis, which should be initiated no later than 4.5 hours after onset of symptoms. Several studies have shown that an attenuation of the inflammatory response in relation to stroke could widen the therapeutic window. However, the immune system has important functions following infarction, such as removal of dead cells and the subsequent astrocytosis as well as prevention of post-ischemic infection. Hence, detailed knowledge concerning the temporal profile of leukocyte infiltration is necessary in order to develop new and effective treatments.The purpose of this review is to determine the temporal profile of leukocyte (neutrophil granulocytes, macrophages and T-cells) infiltration following experimental stroke. We found that the number of neutrophil granulocytes peaks between day 1 and 3 after experimental stroke, with short occlusion times (30 and 60 minutes of middle cerebral artery occlusion (MCAO)) leading to a later peak in response (P <0.001). Macrophages/microglia were found to peak later than day 3 and stay in the infarcted area for longer time periods, whereas duration of occlusion had no influence on the temporal infiltration (P = 0.475). Studies on T-cell infiltration are few; however, a tendency towards infiltration peak at later time points (from day 4 onwards) was seen.This review provides a framework for the instigation of post-stroke anti-inflammatory treatment, which could prove beneficial and widen the therapeutic window compared to current treatment options.
authors.affiliation: Department of Biomedical Sciences, University of Copenhagen, Ole Maaloesvej 5, Copenhagen 2200, Denmark. henrik.hasseldam@bric.ku.dk.
authors.forename: Nina Vindegaard
authors.initials: NV
authors.lastname: Grønberg
authors.forename: Flemming Fryd
authors.initials: FF
authors.lastname: Johansen
authors.forename: Uffe
authors.initials: U
authors.lastname: Kristiansen
authors.forename: Henrik
authors.initials: H
authors.lastname: Hasseldam
mesh_terms: D000818:Animals; D004195:Disease Models, Animal; D006098:Granulocytes / Q000276:immunology* / Q000473:pathology; D008264:Macrophages / Q000276:immunology* / Q000473:pathology; D009504:Neutrophils / Q000276:immunology* / Q000473:pathology; D020521:Stroke / Q000276:immunology* / Q000473:pathology; D013601:T-Lymphocytes / Q000276:immunology* / Q000473:pathology
references.citation: Blood. 2010 May 6;115(18):3835-42
references.pmid: 20215643
references.citation: J Cereb Blood Flow Metab. 1995 Nov;15(6):941-7
references.pmid: 7593354
references.citation: J Cereb Blood Flow Metab. 2012 Apr;32(4):598-611
references.pmid: 22293986
references.citation: Scand J Immunol. 2005 Nov;62(5):481-6
references.pmid: 16305645
references.citation: PLoS One. 2013 Jul 09;8(7):e68428
references.pmid: 23874624
references.citation: Brain Res. 1993 Jul 9;616(1-2):89-98
references.pmid: 8395308
references.citation: Stroke. 2008 Apr;39(4):1121-6
references.pmid: 18323498
references.citation: J Neuroimmunol. 2000 Sep 22;109(2):66-74
references.pmid: 10996208
references.citation: Trends Immunol. 2005 Oct;26(10):550-6
references.pmid: 16109503
references.citation: Stroke. 1994 Jul;25(7):1469-75
references.pmid: 8023364
references.citation: Trends Neurosci. 1999 Sep;22(9):391-7
references.pmid: 10441299
references.citation: BMC Neurosci. 2005 Aug 03;6:49
references.pmid: 16078993
references.citation: BMC Immunol. 2013 Jan 03;14:1
references.pmid: 23286717
references.citation: J Transl Med. 2009 Nov 17;7:97
references.pmid: 19919699
references.citation: Circulation. 2006 May 2;113(17):2035-6
references.pmid: 16651483
references.citation: Neuroscience. 2009 Jul 7;161(3):806-12
references.pmid: 19374937
references.citation: PLoS One. 2011;6(5):e19046
references.pmid: 21625615
references.citation: J Neurol Sci. 2009 Apr 15;279(1-2):70-5
references.pmid: 19185320
references.citation: Oral Microbiol Immunol. 2003 Dec;18(6):364-70
references.pmid: 14622342
references.citation: Hypertension. 2001 Jul;38(1):116-22
references.pmid: 11463771
references.citation: J Leukoc Biol. 2010 May;87(5):779-89
references.pmid: 20130219
references.citation: J Neurosci Res. 2007 Apr;85(5):994-1009
references.pmid: 17265469
references.citation: Cell Death Differ. 2012 May;19(5):756-67
references.pmid: 22052192
references.citation: Immunology. 2010 Feb;129(2):154-69
references.pmid: 20561356
references.citation: Anat Sci Int. 2011 Jun;86(2):86-97
references.pmid: 20809266
references.citation: Brain Res. 1980 Aug 18;195(2):355-62
references.pmid: 6249443
references.citation: Vet Pathol. 2012 Jan;49(1):32-43
references.pmid: 22135019
references.citation: Eur J Pharmacol. 2007 Feb 28;557(2-3):236-44
references.pmid: 17169356
references.citation: Jpn J Pharmacol. 1999 May;80(1):41-8
references.pmid: 10446755
references.citation: J Immunol. 2004 Mar 1;172(5):2731-8
references.pmid: 14978070
references.citation: Nat Med. 2009 Feb;15(2):192-9
references.pmid: 19169263
references.citation: Circulation. 2006 May 2;113(17):2105-12
references.pmid: 16636173
references.citation: Clin Sci (Lond). 2009 Oct 19;118(2):147-57
references.pmid: 19508233
references.citation: Brain Res. 2009 Sep 15;1289:79-84
references.pmid: 19559679
references.citation: J Neurosci Res. 1991 Jul;29(3):336-45
references.pmid: 1656059
references.citation: J Cereb Blood Flow Metab. 2006 Mar;26(3):402-13
references.pmid: 16049425
references.citation: Prog Neurobiol. 1996 Mar-Apr;48(4-5):441-60
references.pmid: 8804116
references.citation: Neuromolecular Med. 2010 Jun;12(2):193-204
references.pmid: 19579016
references.citation: J Neuroimmunol. 1991 Dec;35(1-3):53-64
references.pmid: 1955572
references.citation: Brain. 2011 Mar;134(Pt 3):704-20
references.pmid: 21354973
references.citation: Transplant Proc. 2001 May;33(3):2390-2
references.pmid: 11377571
references.citation: Toxicology. 1988 Feb;48(2):127-39
references.pmid: 2963408
references.citation: Toxicol Appl Pharmacol. 1994 Feb;124(2):248-56
references.pmid: 8122270
references.citation: Stroke. 2011 Jul;42(7):2033-44
references.pmid: 21546487
references.citation: Cerebrovasc Dis. 2002;13(3):198-203
references.pmid: 11914538
references.citation: J Cereb Blood Flow Metab. 2010 Jul;30(7):1306-17
references.pmid: 20145655
references.citation: J Neuroimmunol. 1994 Dec;55(2):195-203
references.pmid: 7530260
references.citation: Transplant Rev (Orlando). 2009 Jan;23(1):1-10
references.pmid: 19027612
references.citation: Stroke. 2002 Feb;33(2):586-92
references.pmid: 11823674
references.citation: Toxicology. 2003 Jun 3;188(1):49-71
references.pmid: 12748041
references.citation: J Allergy Clin Immunol. 2009 May;123(5):977-83; quiz 984-5
references.pmid: 19410687
references.citation: J Mol Neurosci. 1997 Oct;9(2):103-8
references.pmid: 9407391
references.citation: J Cereb Blood Flow Metab. 2007 Dec;27(12):1941-53
references.pmid: 17440490
references.citation: Am J Pathol. 1994 Jan;144(1):188-99
references.pmid: 8291608
references.citation: Curr Opin Neurol. 2001 Feb;14(1):89-94
references.pmid: 11176223
references.citation: J Cereb Blood Flow Metab. 2003 Sep;23(9):1029-39
references.pmid: 12973019
references.citation: Neuroscience. 2002;114(4):1081-90
references.pmid: 12379261
references.citation: Brain Res. 2002 Apr 5;932(1-2):110-9
references.pmid: 11911867
references.citation: Curr Opin Neurol. 2007 Jun;20(3):334-42
references.pmid: 17495630
references.citation: Cerebrovasc Dis. 2009;27 Suppl 1:48-64
references.pmid: 19342833
references.citation: Neurology. 2000 Oct 10;55(7):1052-4
references.pmid: 11061271
references.citation: J Neurol Sci. 1994 Aug;125(1):3-10
references.pmid: 7964886
references.citation: Neuroscience. 2009 Feb 6;158(3):1184-93
references.pmid: 18722511
references.citation: Nat Med. 2009 Aug;15(8):946-50
references.pmid: 19648929